We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JD icon
51
JD.com
JD
$43.1B
$53.2M 0.44%
630,404
– –
EMR icon
52
Emerson Electric
EMR
$84.7B
$51.9M 0.43%
672,176
– –
TGTX icon
53
TG Therapeutics
TGTX
$8.56B
$50.5M 0.42%
1,010,227
– –
ABT icon
54
Abbott
ABT
$189B
$49.2M 0.41%
467,921
+4
+0% +$474
APD icon
55
Air Products & Chemicals
APD
$65.9B
$49M 0.41%
186,878
+3
+0% +$816
JPM icon
56
JPMorgan Chase
JPM
$947B
$48.1M 0.4%
393,893
– –
INCY icon
57
Incyte
INCY
$25.3B
$47.9M 0.4%
573,298
-2
-0% -$171
AVGO icon
58
Broadcom
AVGO
$1.81T
$47.7M 0.4%
1,135,310
– –
AMAT icon
59
Applied Materials
AMAT
$378B
$47.6M 0.4%
574,877
-3
-0% -$331
ONC
60
BeOne Medicines Ltd
ONC
$34B
$47.5M 0.4%
191,344
-5
-0% -$1.66K
AWK icon
61
American Water Works
AWK
$27.3B
$46.9M 0.39%
318,452
+6
+0% +$909
ALL icon
62
Allstate
ALL
$69.4B
$46.2M 0.38%
437,863
– –
BALL icon
63
Ball Corp
BALL
$17.8B
$46M 0.38%
514,108
+5
+0% +$438
MA icon
64
Mastercard
MA
$494B
$45.8M 0.38%
133,504
– –
ROK icon
65
Rockwell Automation
ROK
$52B
$44.6M 0.37%
185,143
+2
+0% +$510
EXEL icon
66
Exelixis
EXEL
$14B
$44.5M 0.37%
2,309,379
+33
+0% +$745
VIPS icon
67
Vipshop
VIPS
$7.13B
$43.2M 0.36%
1,600,094
– –
SPGI icon
68
S&P Global
SPGI
$125B
$41.3M 0.34%
130,663
-3
-0% -$998
LH icon
69
Labcorp
LH
$25.5B
$41.1M 0.34%
244,726
-6
-0% -$1.2K
ON icon
70
ON Semiconductor
ON
$33.2B
$40.5M 0.34%
1,287,909
-1
-0% -$38
EDU icon
71
New Oriental
EDU
$7.97B
$40.1M 0.33%
22,483
-202,347
-90% -$35.3M
MRTX
72
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$39.9M 0.33%
189,100
+2
+0% +$396
MRNA icon
73
Moderna
MRNA
$21.2B
$39.8M 0.33%
396,167
– –
KEYS icon
74
Keysight
KEYS
$51.5B
$39.7M 0.33%
313,332
-11
-0% -$1.56K
MELI icon
75
Mercado Libre
MELI
$95B
$38.9M 0.32%
24,196
– –
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.